lifesciencelaw.ch

 

Coronavirus: AstraZeneca withdraws authorisation application for COVID-19 vaccine in Switzerland

5. November 2021 – AstraZeneca AG announced on 4 November 2021 that it is no longer pursuing marketing authorisation for its COVID-19 vaccine in Switzerland. The company has withdrawn its application for authorisation for its COVID-19 vaccine, which it submitted to Swissmedic in October 2020. This means that there are currently no new authorisation applications pending for COVID-19 vaccines in Switzerland.

For more information, see here.